(Date:11/4/2009)...RLSBAD, Calif., Oct. 23 GenVault C...ample management for genomic discovery, medicine a...is, Ph.D., GenVault,s President and CEO, will be p... place on October 26th and 27th in La Jolla, CA. ,...ide an overview of the company together with recen...
(Date:11/4/2009)... CHAPEL HILL Scientists at the University of Nort...he University of California, San Francisco have de...redict new target diseases for existing drugs. , ...that compares how similar the structures of all kn...artners -- known as ligands -- of disease targets ...
(Date:11/3/2009)...ON, WI, NOVEMBER 4, 2009 -- The world,s greatest ...grape variety, human input, and something called t...rd site, soil, and climate. , Experts will dis... symposium on Wednesday, Nov. 4 in Pittsburgh. "T...esented in two parts at the 2009 Annual Meetings o...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Study points to new uses, unexpected side effects of already existing drugs 2Great wines come from great soils 2Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 1Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 2Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 3Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 4Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 5Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 6Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 7Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 8HPV Vaccine Could Prevent Many Penile Cancers 55330 1HPV Vaccine Could Prevent Many Penile Cancers 55330 2Frank Sadeghi Joins CBCA Administrators Inc as Executive Vice President of Business Development 55326 1Frank Sadeghi Joins CBCA Administrators Inc as Executive Vice President of Business Development 55326 2